Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Protocol for Prevention and Treatment of Laryngospasm and Other Causes of Hypoxemia Based on Identified Risk Factors in Adult Outpatients Undergoing Esophagogastroduodenoscopy (EGD) Under Monitored Anesthesia Care (MAC)

NCT04159116 is registered in ClinicalTrials.gov with Envision Healthcare Scientific Intelligence, Inc. as lead sponsor.

NCT NCT04159116
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04159116 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Protocol for Prevention and Treatment of Laryngospasm and Other Causes of Hypoxemia Based on Identified Risk Factors in Adult Outpatients Undergoing Esophagogastroduodenoscopy (EGD) Under Monitored Anesthesia Care (MAC)
Lead sponsor
Envision Healthcare Scientific Intelligence, Inc.
Phase
Not applicable
Overall status
Completed
Start date
November 4, 2019
Completion date
March 19, 2020
Enrollment
57 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxemia, laryngospasm